QUOTED. 24 May 2019. Rep. Greg Walden.
US lawmakers and health care experts questioned the idea of requiring device manufacturers to report the value of samples they give away to providers at a 21 May congressional hearing on controlling drug prices and other health-care costs. See what Rep. Greg Walden, R-OR, ranking member of the House Energy and Commerce Committee said about it here.
“These free samples are given to providers to pass on to patients either because they lack insurance, or their insurance doesn’t provide robust coverage of drugs or devices.” –Rep. Greg Walden, ranking member, House Energy and Commerce Committee
Click here for a free trial of Medtech Insight